Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

Sex hormones affect liver fat and metabolic health differently in men and women.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Wheat extract supplements reduce hair shedding and improve growth in women with hair loss.

Adrenal tumors can cause hair loss and high testosterone in women.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.